Global Veterinary Software Market OverviewThe global veterinary software market is poised for substantial expansion, with an expected growth rate of 8–10% between 2024 and 2029. As veterinary ...
Benjamin Ball Associates, a London-based executive coaching and presentation training firm, has announced the extension of its services to professionals and organisations in several new districts ...
Here are 27 GI companies that have made notable moves so far this year: 1. Miami-based Gastro Health entered into a partnership with Miami Gastro Health. 2. Atlanta-based United Digestive forged a new ...
A study by Forrester Consulting on behalf of Navan , the leading all-in-one business travel, payments, and expense management platform, found the Navan platform saved customers 16% annually on ...
University of California, Berkeley and University of California, San Francisco researchers today released Pillar (Pillar-0), an open-source AI model that analyzes medical images and recognizes ...
The Texas Tribune on MSN
A small Texas think tank cultivated COVID dissidents. Now they’re running U.S. health policy.
People with ties to Brownstone Institute have significant authority over access to vaccines and scientific research.
ADELAIDE, AU / ACCESS Newswire / November 20, 2025 / Barton Gold Holdings Limited (ASX:BGD) (Barton or the Company) advises that the attached presentation is due to be presented today at the Swiss ...
PRESSADVANTAGE – Stephen Twomey has weighted in with a detailed examination of how the recent Cloudflare outage disrupted global market activity and may have cost financial service brokers an ...
The CNPV program aims to reduce drug review times to 1-2 months, raising concerns about safety and regulatory scrutiny. Critics argue that accelerated timelines may lead to safety issues and strain ...
His institute’s covid contrarians seek to limit the government’s role in protecting Americans from disease. The Austin, Texas ...
NRx has refiled its Abbreviated New Drug Application for KETAFREE™ (preservative free ketamine), received supportive correspondence from FDA, and ...
The CNPV pilot program reduces review times from 10-12 months to 1-2 months, benefiting generics and biosimilars. Companies must align market access, manufacturing, and post-approval readiness with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback